CDC said to delay vaccine panel meeting after lawsuit challenging its composition
Source: SeekingAlpha
2026-02-19 14:10:21 ET
More on Pfizer, Sanofi, etc.
- Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game
- Pfizer: The Rebound Looks Unsustainable
- GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade)
- China drug licensing deals surge nearly 10-fold in value since 2021
- NIH director reportedly being tapped as acting CDC director
Read the full article on Seeking Alpha
For further details see:
CDC said to delay vaccine panel meeting after lawsuit challenging its composition
BioNTech SE
NASDAQ: BNTX
BNTX Trading
-20.72% G/L:
$79.99 Last:
4,729,995 Volume:
$82.81 Open:
BNTX Latest News
March 10, 2026 06:45:00 am
BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update
BNTX Stock Data
$26,377,590,776
95,508,380
N/A
104
N/A
Biotechnology & Life Sciences
Healthcare
DE
Mainz
